RxDoctor Payments Data

Stephen Jenkins

Gerontology · Macon, GANPI 1154882322

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (51.2%), food and beverage and education — rather than concentrated in one kind of arrangement. Medtronic accounts for 60.9% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2022 at $2,561 and has fallen 97.2% since, to $72 in 2025.

$3,293in general payments, 2019–2025

Across 79 payments — averaging $41.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$2K
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$207
  • Johnson & Johnson$185
  • Pfizer$124
  • E.r. Squibb & Sons, L.L.C.$118
  • AbbVie$95
  • plus $558 from 13 others

What the payments were for

  • Travel & lodging$1,68551%
  • Food & beverage$1,53847%
  • Education$702%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,293 in reported general payments places this provider in the 85th percentile of 197 gerontology providers in Georgia.

See all gerontology providers in Georgia

Medicare billing

Part B allowed, 2024
$110,175
Medicare patients
565
Services billed
1,566

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban132$136,734
XareltoRivaroxaban46$34,089
EntrestoSacubitril/Valsartan33$33,925
Flecainide Acetate72$3,088
Mexiletine Hcl19$2,069
Metoprolol Succinate152$1,969
Pindolol12$1,901
Amiodarone Hcl114$1,897
Fludrocortisone Acetate45$1,312
Pyridostigmine Bromide54$1,102
Midodrine Hcl15$786
Furosemide72$407
Nifedipine ErNifedipine17$371
Losartan Potassium47$364
Meclizine Hcl27$317

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$124$136,734132 claims
Johnson & JohnsonXarelto$185$34,08946 claims
NovartisEntresto$53$33,92533 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 197 gerontology providers in Georgia.

Other gerontology in Macon

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →